NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.
Week of April 21-25:
There are no new IPOs scheduled this week. Those listed were previously scheduled and did not price.
Aldeyra Therapeutics Inc. – Burlington, Mass., 2.3 million shares, priced $10 to $12, managed by Aegis Capital. Proposed Nasdaq symbol ALDX. Business: Clinical-stage biotech developing treatments for rare skin and eye diseases. Issue was originally scheduled to price the week of April 7.
Quotient Ltd. – Midlothian, U.K., 5 million ordinary shares, priced $9 to $11, managed by UBS, Baird, and Cowen & Co. Proposed Nasdaq symbol QTNT. Business: Develops quick and comprehensive diagnostic tests for blood diseases. Issue was originally scheduled to price the week of April 14 at a range of $14 to $16.
Scynexis Inc. – Durham, N.C., 7.3 million shares, priced $7 to $8, managed by RBC Capital Markets and Canaccord Genuity. Proposed Nasdaq symbol SCYX. Business: Biotech developing treatments for life-threatening fungal infections. Issue was originally scheduled to price 4.2 million shares the week of March 31 at a range of $12 to $14.